0001144204-18-063348.txt : 20181206
0001144204-18-063348.hdr.sgml : 20181206
20181206132308
ACCESSION NUMBER: 0001144204-18-063348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181203
FILED AS OF DATE: 20181206
DATE AS OF CHANGE: 20181206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ren Ken Keyong
CENTRAL INDEX KEY: 0001545181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20713
FILM NUMBER: 181219992
MAIL ADDRESS:
STREET 1: 9640 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000895051
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581959440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-864-2600
MAIL ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ENTREMED INC
DATE OF NAME CHANGE: 19960415
4
1
tv508522_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-12-03
0
0000895051
CASI Pharmaceuticals, Inc.
CASI
0001545181
Ren Ken Keyong
CASI PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DRIVE, SUITE 300
ROCKVILLE
MD
20850
1
1
0
0
Chief Executive Officer
Stock Options (Right to Buy)
0.99
2018-12-03
4
A
0
720000
0
A
2018-12-03
2027-08-14
Common Stock
720000
720000
D
On August 14, 2017, the reporting person was granted an option to purchase 720,000 shares of common stock that vest upon achievement of certain performance based conditions. The performance based condition was satisfied on December 3, 2018, resulting in vesting of the option.
/s/ Cynthia W. Hu, attorney-in-fact for Ken K. Ren
2018-12-05